Mirum Pharmaceuticals, Inc. announced that on January 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 50,950 shares of common stock and 25,480 restricted stock units to seven new employees under Mirum’s 2020 Inducement Plan.
